Biomarker activity and chronic heart failure in adult patients with congenital heart disease.

Recruiting

• Conditions: congenital heart disease; heart failure; 10007510

• Registration Number: NL-OMON44822
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 602

Inclusion Criteria

Patients to be included must meet the following criteria:
1. Men and women, aged 18 years or older, capable of understanding and signing informed
consent.
2. Patients is known with a congenital heart disease. Cardiac diagnoses are atrial septal defect, ventricular septal defect, pulmonal stenoses, Tetralogy of Fallot, Transposition of the great arteries, eisenmenger syndrome, aortic pathology and Fontan circulation.

Exclusion Criteria

Patients living abroad or who were not Dutch speaking.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Cardiovascular death or complications as heartfailure, hospitalization,<br /><br>reoperation, arrhythmias and thormboembolic events. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>